Sealed Air Opens Singapore Lab to Provide Thermal Package Design and Testing to the Region’s Life Sciences and Food Industries
SINGAPORE, May 22, 2019 – Sealed Air Corporation (NYSE: SEE) announced today the opening of a temperature assurance lab in Singapore to support growth in the life sciences and food industries. It is the company’s first such facility in the Asia Pacific region.
The Singapore lab, along with Sealed Air’s temperature assurance lab at the company’s U.S. headquarters, brings together Sealed Air’s proven expertise in primary food packaging, secondary product packaging and its digital services portfolio to provide end-to-end temperature assurance solutions for product safety and consistency throughout the supply chain.
Supported by Singapore’s Economic Development Board, Sealed Air’s new lab will focus on the application design and testing of custom packaging solutions that protect temperature-sensitive and perishable products for the Asia Pacific region’s life science and food customers and logistics partners. Customized solutions will be developed based on internal payload type, thermal needs, external temperature profiles, shipping lanes and delivery duration.
Specific lab capabilities include:
- Cold chain materials research and development
- Thermal shipper design and pack-out configuration
- Digital thermal simulation and modeling
- Thermal testing
- Customized solution reports certified by the International Safe Transit Association
“Leveraging Sealed Air’s suite of solutions that provide thermal insulation for up to 120 hours, the Singapore lab will provide companies with a one-stop solution for temperature assurance packaging requirements,” said Susan Bell, Sealed Air’s Vice President and General Manager of Bio and Thermal Assurance. “Singapore’s position as a regional bio-pharmaceutical hub, and the city’s excellent connectivity and infrastructure make this location a conducive environment from which Sealed Air can serve customers.”
In the Asia Pacific region, the growing life sciences and food industries are creating opportunities and challenges for one of the most rigorous and demanding segments of logistics: cold chain management. For these industries, the stakes are high if drug and food safety is compromised. Temperature and shock fluctuations occur as products travel through the supply chain from the point of manufacture to the point of consumer delivery and these variations degrade the quality of perishable goods. On average, products go through more than 15 handoffs throughout the supply chain journey and maintaining the desired temperature range for a predefined time is essential to the integrity of these products.
“The Singapore lab signifies Sealed Air’s commitment to doubling its rate of innovation and accelerating its investment in sustainability,” said Sealed Air’s Onat Bayraktar, Vice President, Asia. “As e-commerce surges and online pharmaceutical and food sales increase across the globe, the supply chain is getting more complex. Sealed Air’s goal is to address our customers’ fulfillment challenges by ensuring product safety and reducing product loss throughout the supply chain.”
About Sealed Air
Sealed Air partners with customers to solve their most critical packaging challenges with innovative solutions that leave our world, environment, and communities better than we found them. Our portfolio of widely recognized brands includes Cryovac® food packaging and Bubble Wrap® protective packaging which respectively enable a safer, more efficient food supply chain and protect valuable goods shipped around the world. Sealed Air generated $4.7 billion in sales in 2018 and has approximately 15,500 employees who serve customers in 123 countries. To learn more, visit sealedair.com.
We routinely post important information for investors on our website, www.sealedair.com, in the Investors section. We use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition and results of operations. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as “anticipate,” “believe,” “plan,” “assume,” “could,” “should,” “estimate,” “expect,” “intend,” “potential,” “seek,” “predict,” “may,” “will” and similar references to future periods. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results, expectations regarding the results of restructuring and other programs, anticipated levels of capital expenditures and expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings. The following are important factors that we believe could cause actual results to differ materially from those in our forward-looking statements: global economic and political conditions, currency translation and devaluation effects, changes in raw material pricing and availability, competitive conditions, the success of new product offerings, consumer preferences, the effects of animal and food-related health issues, pandemics, changes in energy costs, environmental matters, the success of our restructuring activities, the success of our financial growth, profitability, cash generation and manufacturing strategies and our cost reduction and productivity efforts, changes in our credit ratings, the tax benefit associated with the Settlement agreement (as defined in our most recent Annual Report on Form 10-K), regulatory actions and legal matters, and the other information referenced in the “Risk Factors” section appearing in our most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, and as revised and updated by our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Any forward-looking statement made by us is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
+65 9644 7865